Trial NCT03026023

View at ClinicalTrials.gov 
Org. Study IDs: 2017P000074

Last trial update was posted on 2018-12-20

MeSH Interventions

Grazoprevir Ribavirin

MeSH Conditions

Hepatitis Hepatitis C

Other Conditions

Cardiac Transplant Disorder

Stopping Reasons

moved forward with another protocol utilizing pan genotypic treatment once it became commercially available and FDA approved

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID